Free Trial
NYSE:NNVC

NanoViricides (NNVC) Stock Price, News & Analysis

NanoViricides logo
$1.60 +0.21 (+14.70%)
Closing price 04:00 PM Eastern
Extended Trading
$1.60 0.00 (0.00%)
As of 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About NanoViricides Stock (NYSE:NNVC)

Key Stats

Today's Range
$1.41
$1.61
50-Day Range
$1.23
$1.79
52-Week Range
$0.94
$2.55
Volume
632,344 shs
Average Volume
242,780 shs
Market Capitalization
$25.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

NanoViricides Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
6th Percentile Overall Score

NNVC MarketRank™: 

NanoViricides scored higher than 6% of companies evaluated by MarketBeat, and ranked 923rd out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for NanoViricides.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of NanoViricides is -2.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of NanoViricides is -2.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    NanoViricides has a P/B Ratio of 2.42. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.62% of the float of NanoViricides has been sold short.
  • Short Interest Ratio / Days to Cover

    NanoViricides has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NanoViricides has recently increased by 175.31%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    NanoViricides does not currently pay a dividend.

  • Dividend Growth

    NanoViricides does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.62% of the float of NanoViricides has been sold short.
  • Short Interest Ratio / Days to Cover

    NanoViricides has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in NanoViricides has recently increased by 175.31%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    NanoViricides has a news sentiment score of 1.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for NanoViricides this week, compared to 0 articles on an average week.
  • Search Interest

    8 people have searched for NNVC on MarketBeat in the last 30 days. This is an increase of 60% compared to the previous 30 days.
  • MarketBeat Follows

    Only 3 people have added NanoViricides to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, NanoViricides insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.60% of the stock of NanoViricides is held by insiders.

  • Percentage Held by Institutions

    Only 10.30% of the stock of NanoViricides is held by institutions.

  • Read more about NanoViricides' insider trading history.
Receive NNVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NanoViricides and its competitors with MarketBeat's FREE daily newsletter.

NNVC Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
NanoViricides Inc.
See More Headlines

NNVC Stock Analysis - Frequently Asked Questions

NanoViricides' stock was trading at $1.43 at the beginning of 2025. Since then, NNVC stock has increased by 11.9% and is now trading at $1.60.

NanoViricides, Inc. (NYSE:NNVC) issued its earnings results on Friday, September, 27th. The company reported ($0.19) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.20) by $0.01.

NanoViricides's stock reverse split on the morning of Tuesday, September 24th 2019.The 1-20 reverse split was announced on Thursday, September 12th 2019. The number of shares owned by shareholders was adjusted after the market closes on Monday, September 23rd 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of NNVC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that NanoViricides investors own include Cytosorbents (CTSO), Rekor Systems (REKR), NVIDIA (NVDA), Micron Technology (MU), Inovio Pharmaceuticals (INO), Meta Platforms (META) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
9/27/2024
Today
7/14/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:NNVC
CIK
1379006
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.70)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.29 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-87.90%
Return on Assets
-78.69%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.44
Quick Ratio
2.47

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.66 per share
Price / Book
2.42

Miscellaneous

Outstanding Shares
16,072,000
Free Float
14,922,000
Market Cap
$25.72 million
Optionable
Optionable
Beta
0.88
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NYSE:NNVC) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners